On August 20, 2010, Octapharma USA Inc. recalled ALL lots of OCTAGAM (Immune Globulin Intravenous (human) 5% Liquid Preparation) currently in the United States. This voluntary market withdrawal was performed pending determination of the cause of strokes and death following use of this product. The FDA reported an unacceptable increase in the number of strokes during or following an injection of the defective lots of IGIV.
Octagam IGIV (Immune Globulin Intravenous) is a sterilized solution made from human plasma. It contains the antibodies to help the human body protect itself against infection from various diseases. Immune globulin is used to treat primary humoral immune deficiency (PI), such as congenital agammaglobulinemia, common variable immunodeficiency, X-linked agammaglobulinemia, Wiskott-Aldrich syndrome and severe combined immunodeficiencies, and to reduce the risk of infection in individuals with poorly functioning immune systems.
If you or someone you know has received this injection and suffered an injury or death as a result, please contact our firm for a free consultation and information regarding a potential claim. Pearson Randall, Gempeler, Schumacher & LaBore, P.A. is a law firm that practices in the areas of personal injury, consumer protection and national pharmaceutical litigation, and is working on issues relevant to this case. Contact Attorney Gale D. Pearson at email@example.com or call 612-767-7500 or toll free at 800-774-0757.
This website information is not intended to provide medical or legal advice, as each situation is different and specific factual information must be obtained before an attorney is able to assess the legal questions relevant to your situation. In addition to providing related information, this blog may also be considered an advertisement for legal services.
Pearson Randall, Gempeler, Schumacher & LaBore, P.A.
AGGRESSIVE AND COMPASSIONATE ATTORNEYS HELPING FAMILIES RECOVER
FROM BAD ACCIDENTS, BAD DRUGS AND BAD PRODUCTS.
612-767-7500 or 800-774-0757 (toll free)
Tags: blood, death, defective blood product, defective plasma, FDA, IgG, IGIV, immune deficiency, Immune Globulin Intravenous, infusion stroke, injection, injury, Octagam, Octapharma, problem, product liability, recall